Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics Inc. (BCAX), sold 73,532 shares at $19.17 ($1.4M) on 2026-03-09, disclosed to the SEC on 2026-03-11.
Open-market sale of $1.4M BCAX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.17 | 36,766 | $705K | 50.0% |
| 2 | $19.17 | 36,766 | $705K | 50.0% |
| Total | $19.17 avg | 73,532 | $1.4M | 100% |
| Filing → |
| BCAX | SELL | 2026-05-20 | $301K | — | Filing → |
| BCAX | SELL | 2026-04-20 | $354K | — | Filing → |
| BCAX | SELL | 2026-03-20 | $565K | — | Filing → |